Dr
Markus
Zoller

Partner & Patent Attorney

Munich Office Heidelberg Office

Life sciences

Telephone. +49(0) 891 259 9600
Mobile. +49(0) 172 852 0370
Email. [email protected]

Experience

The kind of clients Markus works with ranges from single inventors to large-scale enterprises. Besides drafting of patent applications and prosecution, Markus offers guidance to his clients in terms of patent portfolio management and litigation strategies.

Markus advises his clients in the fields of trade mark and design law.

Before starting in a large Munich patent law firm he worked in a patent law firm in New York City.

Markus holds a Bachelor and Master’s degree of Science in molecular Biotechnology at the Technical University in Munich. During his studies Markus worked at the University of Amsterdam and studied one semester at the Nanyang Technological University in Singapore. After three years of research at the Max-Planck Institute for Infectious Biology in Berlin he received his Doctor’s degree in the field of molecular biology, especially (auto) antibodies.

Markus is a Patentanwalt (German Patent Attorney), European Patent Attorney as well as European Trade Mark and Design Attorney.

Qualifications

Patent Attorney

Austria
Europe
Germany

Patentanwalt

Trade Mark Attorney

Austria
Europe
Germany


BSC

BSc in Science

MSC

MSc in Science

PHD

PHD in Immunobiology

Publications

IAM Global Patent Prosecution 2023

View publication online

IAM Patent 1000 2022

View publication online

Conferences: 2020

January 29th 2020

AIPLA

Attended

Conferences: 2018

October 18th 2018

APAA

Attended

CSR

Markus is providing training sessions to German Patent and Trade Mark Attorney and European Patent Attorney Trainees and also to support staff.

Further, he is a member of the examination board for German patent paralegals (Patentanwaltsfachangestellte).

Related News

Event - 8th-9th February 2023

5th Annual Microbiome & Probiotic Conference 2023

The 5th Annual MarketsandMarkets Next Gen Microbiome and Probiotics Conference will take place in San Diego on the 8th-9th of February. This conference will enable you to learn about microbial …

Event details
Event - 17th January 2023

CIPA Webinar: Enhancing Diversity in the Patent Profession How Can I Help

CIPA hosted a webinar to discuss ‘Enhancing diversity in the patent profession.’ Date Tuesday 17 January, 2023 Time 12.30pm – 1.30pm (GMT) Equity, diversity and inclusion has been in the …

Event details

LiDAR: A Significant Support Technology at CES

When visiting CES’ one thing that struck me was the number of companies demonstrating LiDAR technology. LiDAR has been around since the 1960s and was originally developed for aerospace use, …

Read article

Parallel importation of pharmaceuticals – when is repackaging necessary?

The repackaging of pharmaceutical products by parallel importers is a long debated subject. The above question was reconsidered in a set of judgements by the CJEU in November last year …

Read article

Healthcare and Climate Change

Can we find a balance between intellectual property rights and public health needs when tackling the climate crisis? “The world faces a critical juncture. A health-centred, aligned response to the …

Read article

Navigating the CRISPR IP confusion

It is just over 10 years since the Science publication of Jinek et al. showed for the first time that DNA cleavage could be achieved in vitro with a Cas9 …

Read article

Trade mark protection for digital health products

The use and creation of digital healthcare products is on the rise as companies look to create a unique selling point and a differentiator in a crowded market. One of …

Read article

CRISPR Edited T cells win the TvT Battle

T-cells which have been modified using CRISPR base editing technology have been successfully used to treat T-cell acute lymphoblastic leukaemia for the first time {1}. A 13 year old patient …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.